The clinical presentation and the histological findings were highly suggestive for SchS, even if the patients lacked monoclonal gammopathy (confirmed with sensitive immunofixation); thus, we decided to try IL-1 blockade therapy. Here, IL1B is linked to monoclonal gammopathy.